» Articles » PMID: 24478701

Are Mast Cells Instrumental for Fibrotic Diseases?

Overview
Journal Front Pharmacol
Date 2014 Jan 31
PMID 24478701
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity. IPF has a heterogeneous clinical course; however the median survival after diagnosis is only 3-5 years. The pharmaceutical and biotechnology industry has made many attempts to find effective treatments for IPF, but the disease has so far defied all attempts at therapeutic intervention. Clinical trial failures may arise for many reasons, including disease heterogeneity, lack of readily measurable clinical end points other than overall survival, and, perhaps most of all, a lack of understanding of the underlying molecular mechanisms of the progression of IPF. The precise link between inflammation and fibrosis remains unclear, but it appears that immune cells can promote fibrosis by releasing fibrogenic factors. So far, however, therapeutic approaches targeting macrophages, neutrophils, or lymphocytes have failed to alter disease pathogenesis. A new cell to garner research interest in fibrosis is the mast cell. Increased numbers of mast cells have long been known to be present in pulmonary fibrosis and clinically correlations between mast cells and fibrosis have been reported. More recent data suggests that mast cells may contribute to the fibrotic process by stimulating fibroblasts resident in the lung, thus driving the pathogenesis of the disease. In this review, we will discuss the mast cell and its physiological role in tissue repair and remodeling, as well as its pathological role in fibrotic diseases such as IPF, where the process of tissue repair and remodeling is thought to be dysregulated.

Citing Articles

Mast Cell Carboxypeptidase A3 Is Associated with Pulmonary Fibrosis Secondary to COVID-19.

Meneses-Preza Y, Martinez-Martinez R, Meixueiro-Calderon C, Hernandez U, Retana E, Ponce-Regalado M Int J Mol Sci. 2024; 25(22).

PMID: 39596322 PMC: 11594788. DOI: 10.3390/ijms252212258.


Notch signaling regulates pulmonary fibrosis.

Zhang X, Xu Z, Chen Q, Zhou Z Front Cell Dev Biol. 2024; 12:1450038.

PMID: 39450276 PMC: 11499121. DOI: 10.3389/fcell.2024.1450038.


The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities.

Napolitano F, Rossi F, De Paulis A, Lavecchia A, Montuori N Int J Mol Sci. 2024; 25(6).

PMID: 38542130 PMC: 10969995. DOI: 10.3390/ijms25063156.


The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis.

Xu Y, Lan P, Wang T Medicina (Kaunas). 2023; 59(11).

PMID: 38004032 PMC: 10672798. DOI: 10.3390/medicina59111984.


Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia.

Han I, Kim J, Ryu J Parasites Hosts Dis. 2023; 61(1):2-14.

PMID: 37170459 PMC: 10230662. DOI: 10.3347/PHD.22160.


References
1.
Kawanami O, Ferrans V, Fulmer J, Crystal R . Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest. 1979; 40(6):717-34. View

2.
Stramer B, Mori R, Martin P . The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007; 127(5):1009-17. DOI: 10.1038/sj.jid.5700811. View

3.
Dougherty R, Sidhu S, Raman K, Solon M, Solberg O, Caughey G . Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol. 2010; 125(5):1046-1053.e8. PMC: 2918406. DOI: 10.1016/j.jaci.2010.03.003. View

4.
Okazaki T, Hirota S, Xu Z, Maeyama K, Nakama A, Kawano S . Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab Invest. 1998; 78(11):1431-8. View

5.
Weller K, Foitzik K, Paus R, Syska W, Maurer M . Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006; 20(13):2366-8. DOI: 10.1096/fj.06-5837fje. View